blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0952154

EP0952154 - N-acyl and N-aroyl aralkyl amides [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  24.06.2005
Database last updated on 20.09.2024
Most recent event   Tooltip24.06.2005No opposition filed within time limitpublished on 10.08.2005  [2005/32]
Applicant(s)For all designated states
Pfizer Products Inc.
Eastern Point Road
Groton, CT 06340 / US
[N/P]
Former [2004/34]For all designated states
Pfizer Products Inc.
Eastern Point Road
Groton, Connecticut 06340 / US
Former [1999/43]For all designated states
Pfizer Products Inc.
Eastern Point Road
Groton, Connecticut 06340 / US
Inventor(s)01 / Howard, Harry Ralph
272 Westwoods Terrace
Bristol, Connecticut 06010 / US
[1999/43]
Representative(s)Simpson, Alison Elizabeth Fraser, et al
Urquhart-Dykes & Lord LLP The Podium
1 Eversholt Street
London NW1 2DN / GB
[N/P]
Former [1999/43]Simpson, Alison Elizabeth Fraser, et al
Urquhart-Dykes & Lord, 91 Wimpole Street
London W1M 8AH / GB
Application number, filing date99302284.725.03.1999
[1999/43]
Priority number, dateUS19980081970P16.04.1998         Original published format: US 81970 P
[1999/43]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP0952154
Date:27.10.1999
Language:EN
[1999/43]
Type: A3 Search report 
No.:EP0952154
Date:05.01.2000
[2000/01]
Type: B1 Patent specification 
No.:EP0952154
Date:18.08.2004
Language:EN
[2004/34]
Search report(s)(Supplementary) European search report - dispatched on:EP18.11.1999
ClassificationIPC:C07D333/38, A61K31/38, C07D295/12, C07D207/09, C07D471/04, C07D487/04, C07D211/26, C07C233/73, C07C323/42, C07D295/08, C07D207/14, C07D213/81, C07D453/02, C07D471/08, C07D487/08, C07D241/42, C07D207/08, C07D263/34, C07D209/42, C07D241/04
[2000/01]
CPC:
C07D295/135 (EP,US); A61P1/00 (EP); A61P15/00 (EP);
A61P15/10 (EP); A61P25/04 (EP); A61P25/06 (EP);
A61P25/16 (EP); A61P25/18 (EP); A61P25/22 (EP);
A61P25/24 (EP); A61P25/28 (EP); A61P25/30 (EP);
A61P3/00 (EP); A61P3/04 (EP); A61P35/00 (EP);
A61P43/00 (EP); A61P9/00 (EP); A61P9/12 (EP);
C07D295/13 (EP,US); C07D333/38 (EP,US) (-)
Former IPC [1999/43]C07D333/38, A61K31/38
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   NL,   PT,   SE [2000/37]
Former [1999/43]AT,  BE,  CH,  CY,  DE,  DK,  ES,  FI,  FR,  GB,  GR,  IE,  IT,  LI,  LU,  MC,  NL,  PT,  SE 
TitleGerman:N-Acyl und N-Aroyl Aralkylamide[1999/43]
English:N-acyl and N-aroyl aralkyl amides[1999/43]
French:N-acyl et N-aroyl aralkyl amides[1999/43]
Examination procedure12.04.1999Examination requested  [1999/43]
14.08.2003Despatch of a communication from the examining division (Time limit: M04)
19.12.2003Reply to a communication from the examining division
16.02.2004Communication of intention to grant the patent
14.06.2004Fee for grant paid
14.06.2004Fee for publishing/printing paid
Opposition(s)19.05.2005No opposition filed within time limit [2005/32]
Fees paidRenewal fee
27.01.2001Renewal fee patent year 03
10.01.2002Renewal fee patent year 04
22.01.2003Renewal fee patent year 05
14.02.2004Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[Y]WO9734883  (ASTRA AB [SE], et al) [Y] 1-24 * see e.g. page 4, formula I, in particular meaning of "Y" *;
 [Y]EP0810220  (PFIZER [US]) [Y] 1-24 * claim 1 *;
 [A]WO9814433  (PFIZER [US], et al) [A] 1-24* claim 1 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.